Cargando…
Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252923/ https://www.ncbi.nlm.nih.gov/pubmed/33375771 http://dx.doi.org/10.3324/haematol.2020.265611 |
| _version_ | 1783717399347855360 |
|---|---|
| author | Costacurta, Matteo Vervoort, Stephin J Hogg, Simon J Martin, Benjamin P Johnstone, Ricky W Shortt, Jake |
| author_facet | Costacurta, Matteo Vervoort, Stephin J Hogg, Simon J Martin, Benjamin P Johnstone, Ricky W Shortt, Jake |
| author_sort | Costacurta, Matteo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8252923 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82529232021-07-14 Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma Costacurta, Matteo Vervoort, Stephin J Hogg, Simon J Martin, Benjamin P Johnstone, Ricky W Shortt, Jake Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-12-30 /pmc/articles/PMC8252923/ /pubmed/33375771 http://dx.doi.org/10.3324/haematol.2020.265611 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Costacurta, Matteo Vervoort, Stephin J Hogg, Simon J Martin, Benjamin P Johnstone, Ricky W Shortt, Jake Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma |
| title | Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma |
| title_full | Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma |
| title_fullStr | Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma |
| title_full_unstemmed | Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma |
| title_short | Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma |
| title_sort | whole genome crispr screening identifies top2b as a potential target for imid sensitization in multiple myeloma |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252923/ https://www.ncbi.nlm.nih.gov/pubmed/33375771 http://dx.doi.org/10.3324/haematol.2020.265611 |
| work_keys_str_mv | AT costacurtamatteo wholegenomecrisprscreeningidentifiestop2basapotentialtargetforimidsensitizationinmultiplemyeloma AT vervoortstephinj wholegenomecrisprscreeningidentifiestop2basapotentialtargetforimidsensitizationinmultiplemyeloma AT hoggsimonj wholegenomecrisprscreeningidentifiestop2basapotentialtargetforimidsensitizationinmultiplemyeloma AT martinbenjaminp wholegenomecrisprscreeningidentifiestop2basapotentialtargetforimidsensitizationinmultiplemyeloma AT johnstonerickyw wholegenomecrisprscreeningidentifiestop2basapotentialtargetforimidsensitizationinmultiplemyeloma AT shorttjake wholegenomecrisprscreeningidentifiestop2basapotentialtargetforimidsensitizationinmultiplemyeloma |